Outcome after 3rdLine Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study

MLA

Ludvigsen Al-Mashhadi, Ahmed, et al. “Outcome after 3rdLine Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study.” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 6706–07. EBSCOhost, https://doi.org/10.1182/blood-2022-167897.

APA

Ludvigsen Al-Mashhadi, A., Jakobsen, L. H., Brown, P. de N., Ortved Gang, A., Thorsteinsson, A.-L., Rasoul, K., Melchior Heissmann, J., Buch Tøstesen, M., Nieman Christoffersen, M., Jelicic, J., Bøgh Jørgensen, J., Thomsen, T., Dessau-Arp, A., Andersen, A. P., Frederiksen, M., Pedersen, P. T., Clausen, M. R., Jørgensen, J., Poulsen, C. B., … Larsen, T. S. (2022). Outcome after 3rdLine Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study. Blood, 140(1, Number 1 Supplement 1), 6706–6707. https://doi.org/10.1182/blood-2022-167897

Chicago

Ludvigsen Al-Mashhadi, Ahmed, Lasse Hjort Jakobsen, Peter de Nully Brown, Anne Ortved Gang, Anne-Luise Thorsteinsson, Kaziwa Rasoul, Judith Melchior Heissmann, et al. 2022. “Outcome after 3rdLine Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study.” Blood 140 (1, Number 1 Supplement 1): 6706–7. doi:10.1182/blood-2022-167897.